Protagonist Therapeutics, Inc. (PTGX)
92.08
+3.69
(+4.17%)
USD |
NASDAQ |
Feb 27, 16:00
92.86
+0.78
(+0.85%)
After-Hours: 06:13
Protagonist Therapeutics Research and Development Expense (TTM) : 159.29M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Johnson & Johnson | 14.72B |
| ADMA Biologics, Inc. | 4.761M |
| Glaukos Corp. | 150.61M |
| Krystal Biotech, Inc. | 55.08M |
| Olema Pharmaceuticals, Inc. | 146.78M |